Ovarian Cancer Drug Has Been Found

A study, found a drug that can increase the life expectancy of a patient's ovarian cancer up to eight months, and this is the biggest breakthrough in 20 years womb cancer treatment efforts ovary. 

British researchers found Avastin, used to treat breast and colon cancer, and is also effective against ovarian cancer.

This disease has been called the silent killer because it often has no symptoms at an early stage and 80 percent of the cases it has spread undetected. Currently, there is only treatment of chemotherapy followed by surgery.

Annwen Jones, chief executive of Target Ovarian Cancer Charity, said "This is a glimmer of hope that there is significant progress in treatment for ovarian cancer in the community," "There is a moral obligation to ensure that Avastin fast tracked through the regulatory process required," as quoted by the Daily Mail . The study involved more than 1,500 women across Europe with advanced-stage ovarian cancer.

Research leader Charlie Gourley, of Edinburgh Cancer Research Centre, said, "We want to make ovarian cancer a chronic rather than fatal, disease." Roche, which manufactures the drug, has applied to the European Medicines Agency for a license to use it to treat ovarian cancer, which means it can be available before the end of the year.

Tweet